These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15897934)

  • 1. Cancer treatment-induced bone loss in patients with breast or prostate cancer.
    Maxwell C; Viale PH
    Oncol Nurs Forum; 2005 May; 32(3):589-603. PubMed ID: 15897934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-treatment-induced bone loss, part 2.
    Michaud LB; Goodin S
    Am J Health Syst Pharm; 2006 Mar; 63(6):534-46. PubMed ID: 16522890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-treatment-induced bone loss, part 1.
    Michaud LB; Goodin S
    Am J Health Syst Pharm; 2006 Mar; 63(5):419-30. PubMed ID: 16484516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
    Brufsky AM
    Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer Treatment-Induced Bone Loss(CTIBL)].
    Fukumoto S; Matsumoto T
    Gan To Kagaku Ryoho; 2018 Dec; 45(12):1685-1689. PubMed ID: 30587719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment-induced bone loss in breast and prostate cancer.
    Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
    J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer treatment-induced bone loss. Treatment for breast cancer].
    Yamada K; Kohno N
    Clin Calcium; 2008 Apr; 18(4):507-17. PubMed ID: 18379033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiresorptive therapy in the management of cancer treatment-induced bone loss.
    Garg A; Leitzel K; Ali S; Lipton A
    Curr Osteoporos Rep; 2015 Apr; 13(2):73-7. PubMed ID: 25575469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL].
    Takahashi S
    Clin Calcium; 2011 Mar; 21(3):447-53. PubMed ID: 21358067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)].
    Takahashi S
    Clin Calcium; 2011 Aug; 21(8):1239-47. PubMed ID: 21814031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward new horizons: the future of bisphosphonate therapy.
    Lipton A
    Oncologist; 2004; 9 Suppl 4():38-47. PubMed ID: 15459428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer.
    Michaud LB
    Am J Health Syst Pharm; 2010 Apr; 67(7 Suppl 3):S20-30; quiz S31-3. PubMed ID: 20332495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and implications of cancer treatment-induced bone loss.
    Theriault RL
    Oncology (Williston Park); 2004 May; 18(5 Suppl 3):11-5. PubMed ID: 15202582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal health in breast cancer survivors.
    Bruyère O; Bergmann P; Cavalier E; Gielen E; Goemaere S; Kaufman JM; Rozenberg S; Body JJ
    Maturitas; 2017 Nov; 105():78-82. PubMed ID: 28838807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody.
    von Moos R; Costa L; Gonzalez-Suarez E; Terpos E; Niepel D; Body JJ
    Cancer Treat Rev; 2019 Jun; 76():57-67. PubMed ID: 31136850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy with bone-targeted agents.
    Wilson C; Coleman RE
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):241-50. PubMed ID: 21785355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone loss in patients with breast or prostate cancer.
    Hu MI; Gagel RF; Jimenez C
    Curr Osteoporos Rep; 2007 Dec; 5(4):170-8. PubMed ID: 18430392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term implications of bone loss in breast cancer.
    Aapro MS
    Breast; 2004 Dec; 13 Suppl 1():S29-37. PubMed ID: 15585380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.